Login / Signup

Gene therapy with RALA/iNOS composite nanoparticles significantly enhances survival in a model of metastatic prostate cancer.

Cian M McCruddenJohn W McBrideJoanne McCaffreyEmma M McErleanNicholas J DunneVicky L KettJonathan A CoulterTracy RobsonHelen O McCarthy
Published in: Cancer nanotechnology (2018)
These studies further validate RALA as a genetic cargo delivery vehicle and iNOS as a potent therapy for the treatment of cancer.
Keyphrases
  • gene therapy
  • prostate cancer
  • nitric oxide synthase
  • papillary thyroid
  • squamous cell carcinoma
  • small cell lung cancer
  • radical prostatectomy
  • squamous cell
  • anti inflammatory
  • nitric oxide
  • copy number